ATXS Stock Analysis: Buy, Sell, or Hold?
ATXS - Astria Therapeutics, Inc. Common Stock
$12.58
0.08 (0.64%)
▲
5d:
+0.32%
30d:
-1.95%
90d:
+3.45%
BUY
MODERATE Confidence
Analysis Updated: Jan 22, 2026 12:00 AM ET
Earnings: May 07, 2026
Get Alerted When ATXS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ATXS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ATXS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ATXS is currently trading at $12.58, which is considered fair based on recent price action.
Technical Outlook: Technically, ATXS is in a strong uptrend. The price is currently testing key support at $12.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.60 (+95.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ATXS is in a strong uptrend. The price is currently testing key support at $12.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.60 (+95.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
58/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading 95.5% below Wall St target ($24.60)
Support & Resistance Levels
Support Level
$12.24
Resistance Level
$13.27
Current Trend
Strong Uptrend
Technical data as of
Jan 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.34
Wall Street Target
$24.60
(+95.5%)
Share & Embed Analysis
Last updated: April 02, 2026 12:46 PM ET
Data refreshes hourly during market hours. Next update: 1:46 PM
Data refreshes hourly during market hours. Next update: 1:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATXS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$134 | 61 BUY |
